Three-year survival update confirms efficacy of pembrolizumab in non-small cell lung cancer

Three-year survival update confirms efficacy of pembrolizumab in non-small cell lung cancer - Healio

- September 23, 2019

Three-year survival update confirms efficacy of pembrolizumab in non-small cell lung cancer Healio

BARCELONA — First-line pembrolizumab monotherapy conferred a durable long-term OS benefit compared with chemotherapy for patients with metastatic, ...

Search This Blog

Lung Cancer

Three-year survival update confirms efficacy of pembrolizumab in non-small cell lung cancer - Healio

Comments

Post a Comment

Popular posts from this blog

Beagles, other dogs could be used to help in early detection of lung cancers, study finds - Fox 32 Chicago

Not An Ordinary Cough: Lung Cancer Symptoms That You Might Neglect - International Business Times

Beagles, other dogs could be used to help in early detection of lung cancers, study finds - Fox 32 Chicago